Lung Micobiome in Lung Cancer

J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Mincholé (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain)

Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Session: Biological mechanisms of lung cancer
Session type: E-poster session
Number: 1770

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Mincholé (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain). Lung Micobiome in Lung Cancer. 1770

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung Microbiota and Streptococcal enrichment in Central Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


Lung Cancer and bronchial infection
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Pretreatment Evaluation on Non-Small-cell Lung Cancer
Source: Guideline 1997
Year: 1997

Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


The Burden of Asymptomatic Lung Cancer
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019

Symptom-to-treatment intervals in lung cancer
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Lung Cancer vs. „Young Cancer“ – Is There a Difference?
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021


The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


Determinants of Respiratory Muscle Strength in Lung Cancer
Source: International Congress 2019 – New views on testing and training of respiratory muscles
Year: 2019

Lung Volume Reduction Surgery for Emphysema
Source: Eur Respir J 2004; 24 : 713
Year: 2004


Pathology of Vaping-Associated Lung Injury
Source: Virtual Congress 2020 – E-cigarette or Vaping, product use Associated Lung Injury (EVALI)
Year: 2020


Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018



Resected Non-Small Cell Lung Cancer : A 5-year Experience
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Chaperone-Mediated Autophagy-Dependent Chemoresistance in Non-Small Cell Lung Cancer
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019



Lung tumours
Source: Eur Respir Monogr 2018; 79: 115-128
Year: 2018


Lung cancer
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014


Lung cancer
Source: Breathe 2016; 12: 392-399
Year: 2016